GlassScriptPhysician profile
Bradley M Watts
NPI 1043741929
$2,906.72
in general payments reported to CMS, 2019-2025
37 companies · $606 in 2025
The $606 reported for 2025 was more than what 77% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $35.78 · 2021: $54.29 · 2022: $633 · 2023: $960 · 2024: $618 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,183.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $712.60 | 2022-2025 | Vraylar, Qulipta, Ubrelvy |
| Lilly USA, LLC | $441.20 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $362.54 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $120.33 | 2022-2024 | Gardasil 9, Vaxelis, Vaxneuvance |
| Dynavax Technologies Corporation | $102.54 | 2022-2024 | Heplisav-B |
| Bayer Healthcare Pharmaceuticals INC. | $100.42 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $91.92 | 2020-2025 | Breztri |
| Ultragenyx Pharmaceutical INC. | $58.50 | 2022-2023 | Crysvita |
| Lucid Diagnostics INC. | $56.31 | 2022-2023 | |
| Edwards Lifesciences Corporation | $55.53 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Organon LLC | $53.75 | 2021-2023 | Nexplanon |
| Otsuka America Pharmaceutical, INC. | $53.71 | 2025 | Rexulti |
| Idorsia Pharmaceuticals US INC | $49.96 | 2022-2023 | Quviviq |
| Viiv Healthcare Company | $45.44 | 2024 | Apretude |
| Janssen Pharmaceuticals, INC | $45.41 | 2022-2025 | Spravato |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Watts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.